Insiders · DTOC

Vance Wright-Browne

Director at American Oncology Network, Inc. (DTOC) since September 2023

Vance Wright-Browne has filed 1 insider report with the SEC since September 2023, as director at American Oncology Network, Inc. (DTOC). The latest filing, on September 20, 2023, is a Form 3: Vance Wright-Browne became an insider at American Oncology Network, Inc. (DTOC).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Vance Wright-Browne is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
American Oncology Network, Inc. logo
DTOC
American Oncology Network, Inc.
Directorsince September 2023Sep 20, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Questions about Vance Wright-Browne

What is Vance Wright-Browne's role at American Oncology Network, Inc.?
Vance Wright-Browne reports to the SEC as director at American Oncology Network, Inc. (DTOC), according to the latest filing on September 20, 2023.
Has Vance Wright-Browne bought or sold stock recently?
No open-market purchases or sales by Vance Wright-Browne are on file.
How do I get alerts when Vance Wright-Browne files?
Follow Vance Wright-Browne on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Vance Wright-Browne (SEC CIK 0001984145). Totals count each trade once, skipping amendments whose original is on file, from Sep 20, 2023 on. View on SEC EDGAR · Get this as JSON